-
1
-
-
84877669189
-
Evaluation of individuals with pulmonary nodules: When is it lung cancer? Diagnosis and management of lung cancer, 3rd ed: American college of chest physicians evidence-based clinical practice guidelines
-
5 Suppl
-
Gould MK, Donington J, Lynch WR, Evaluation of individuals with pulmonary nodules: when is it lung cancer? Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 2013 143 5 Suppl e93S 120S
-
(2013)
Chest
, vol.143
, pp. e93S-120S
-
-
Gould, M.K.1
Donington, J.2
Lynch, W.R.3
-
2
-
-
79952415252
-
Emerging molecular biomarkers-blood-based strategies to detect and monitor cancer
-
Hanash SM, Baik CS, Kallioniemi O, Emerging molecular biomarkers-blood-based strategies to detect and monitor cancer. Nat Rev Clin Oncol 2011 8 142 150
-
(2011)
Nat Rev Clin Oncol
, vol.8
, pp. 142-150
-
-
Hanash, S.M.1
Baik, C.S.2
Kallioniemi, O.3
-
3
-
-
0003964363
-
-
American Cancer Society Atlanta: American Cancer Society
-
American Cancer Society Cancer Facts & Figures 2013 2013 Atlanta: American Cancer Society
-
(2013)
Cancer Facts & Figures 2013
-
-
-
4
-
-
84883325090
-
What the heck is a "nodule"? A qualitative study of veterans with pulmonary nodules
-
Slatore CG, Press N, Au DH, Curtis JR, Wiener RS, Ganzini L, What the heck is a "nodule"? A qualitative study of veterans with pulmonary nodules. Ann Am Thorac Soc 2013 10 330 335
-
(2013)
Ann Am Thorac Soc
, vol.10
, pp. 330-335
-
-
Slatore, C.G.1
Press, N.2
Au, D.H.3
Curtis, J.R.4
Wiener, R.S.5
Ganzini, L.6
-
5
-
-
84874976080
-
What do you mean, a spot?: A qualitative analysis of patients' reactions to discussions with their doctors about pulmonary nodules
-
Wiener RS, Gould MK, Woloshin S, Schwartz LM, Clark JA., What do you mean, a spot?: A qualitative analysis of patients' reactions to discussions with their doctors about pulmonary nodules. Chest 2013 143 672 677
-
(2013)
Chest
, vol.143
, pp. 672-677
-
-
Wiener, R.S.1
Gould, M.K.2
Woloshin, S.3
Schwartz, L.M.4
Clark, J.A.5
-
6
-
-
84928769731
-
The thing is not knowing': Patients' perspectives on surveillance of an indeterminate pulmonary nodule
-
Epub ahead of print
-
Wiener RS, Gould MK, Woloshin S, Schwartz LM, Clark JA., 'The thing is not knowing': patients' perspectives on surveillance of an indeterminate pulmonary nodule. Health Expect 2012 Dec 16. [Epub ahead of print
-
(2012)
Health Expect
-
-
Wiener, R.S.1
Gould, M.K.2
Woloshin, S.3
Schwartz, L.M.4
Clark, J.A.5
-
7
-
-
77951482885
-
Outcomes of interest in evidence-based evaluations of genetic tests
-
EGAPP Working Group
-
Botkin JR, Teutsch SM, Kaye CI, EGAPP Working Group Outcomes of interest in evidence-based evaluations of genetic tests. Genet Med 2010 12 228 235
-
(2010)
Genet Med
, vol.12
, pp. 228-235
-
-
Botkin, J.R.1
Teutsch, S.M.2
Kaye, C.I.3
-
8
-
-
84884908621
-
Screening for lung cancer: The us studies
-
Midthun DE, Jett JR, Screening for lung cancer: the US studies. J Surg Oncol 2013 108 275 279
-
(2013)
J Surg Oncol
, vol.108
, pp. 275-279
-
-
Midthun, D.E.1
Jett, J.R.2
-
9
-
-
34249803223
-
Biomarkers for lung cancer: Clinical uses
-
Greenberg AK, Lee MS, Biomarkers for lung cancer: clinical uses. Curr Opin Pulm Med 2007 13 249 255
-
(2007)
Curr Opin Pulm Med
, vol.13
, pp. 249-255
-
-
Greenberg, A.K.1
Lee, M.S.2
-
10
-
-
84862849740
-
Added value of a serum proteomic signature in the diagnostic evaluation of lung nodules
-
Pecot CV, Li M, Zhang XJ, Added value of a serum proteomic signature in the diagnostic evaluation of lung nodules. Cancer Epidemiol Biomarkers Prev 2012 21 786 792
-
(2012)
Cancer Epidemiol Biomarkers Prev
, vol.21
, pp. 786-792
-
-
Pecot, C.V.1
Li, M.2
Zhang, X.J.3
-
11
-
-
84871940924
-
Development and validation of a plasma biomarker panel for discerning clinical significance of indeterminate pulmonary nodules
-
Daly S, Rinewalt D, Fhied C, Development and validation of a plasma biomarker panel for discerning clinical significance of indeterminate pulmonary nodules. J Thorac Oncol 2013 8 31 36
-
(2013)
J Thorac Oncol
, vol.8
, pp. 31-36
-
-
Daly, S.1
Rinewalt, D.2
Fhied, C.3
-
12
-
-
84859047790
-
Peripheral immune cell gene expression predicts survival of patients with non-small cell lung cancer
-
Kossenkov AV, Dawany N, Evans TL, Peripheral immune cell gene expression predicts survival of patients with non-small cell lung cancer. PLoS One 2012 7 e34392
-
(2012)
PLoS One
, vol.7
, pp. e34392
-
-
Kossenkov, A.V.1
Dawany, N.2
Evans, T.L.3
-
13
-
-
84655176390
-
Exhaled breath analysis with a colorimetric sensor array for the identification and characterization of lung cancer
-
Mazzone PJ, Wang XF, Xu Y, Exhaled breath analysis with a colorimetric sensor array for the identification and characterization of lung cancer. J Thorac Oncol 2012 7 137 42
-
(2012)
J Thorac Oncol
, vol.7
, pp. 137-142
-
-
Mazzone, P.J.1
Wang, X.F.2
Xu, Y.3
-
14
-
-
84977478146
-
Microrna signatures in tissues and plasma predict development and prognosis of computed tomography detected lung cancer
-
Boeri M, Verri C, Conte D, MicroRNA signatures in tissues and plasma predict development and prognosis of computed tomography detected lung cancer. Proc Natl Acad Sci U S A 2011 108 3713 3718
-
(2011)
Proc Natl Acad Sci U S A
, vol.108
, pp. 3713-3718
-
-
Boeri, M.1
Verri, C.2
Conte, D.3
-
15
-
-
79960076353
-
Earlycdt-lung: An immunobiomarker test as an aid to early detection of lung cancer
-
Lam S, Boyle P, Healey GF, EarlyCDT-Lung: an immunobiomarker test as an aid to early detection of lung cancer. Cancer Prev Res (Phila) 2011 4 1126 1134
-
(2011)
Cancer Prev Res (Phila
, vol.4
, pp. 1126-1134
-
-
Lam, S.1
Boyle, P.2
Healey, G.F.3
-
16
-
-
78650121234
-
Unlocking biomarker discovery: Large scale application of aptamer proteomic technology for early detection of lung cancer
-
Ostroff RM, Bigbee WL, Franklin W, Unlocking biomarker discovery: large scale application of aptamer proteomic technology for early detection of lung cancer. PLoS One 2010 5 e15003
-
(2010)
PLoS One
, vol.5
, pp. e15003
-
-
Ostroff, R.M.1
Bigbee, W.L.2
Franklin, W.3
-
17
-
-
84866508033
-
The state of molecular biomarkers for the early detection of lung cancer
-
Hassanein M, Callison JC, Callaway-Lane C, Aldrich MC, Grogan EL, Massion PP, The state of molecular biomarkers for the early detection of lung cancer. Cancer Prev Res (Phila) 2012 5 992 1006
-
(2012)
Cancer Prev Res (Phila
, vol.5
, pp. 992-1006
-
-
Hassanein, M.1
Callison, J.C.2
Callaway-Lane, C.3
Aldrich, M.C.4
Grogan, E.L.5
Massion, P.P.6
-
18
-
-
84866178457
-
New and improved proteomics technologies for understanding complex biological systems: Addressing a grand challenge in the life sciences
-
Workshop Participants
-
Hood LE, Omenn GS, Moritz RL, Workshop Participants New and improved proteomics technologies for understanding complex biological systems: addressing a grand challenge in the life sciences. Proteomics 2012 12 2773 2783
-
(2012)
Proteomics
, vol.12
, pp. 2773-2783
-
-
Hood, L.E.1
Omenn, G.S.2
Moritz, R.L.3
-
19
-
-
78651394465
-
Bring on the biomarkers
-
Poste G, Bring on the biomarkers. Nature 2011 469 156 157
-
(2011)
Nature
, vol.469
, pp. 156-157
-
-
Poste, G.1
-
20
-
-
85030387810
-
Evolution of translational omics: Lessons learned and the path forward
-
CotRoO-BTfPPOiC, Services BoHC, Policy BoHS
-
Micheel CM, Nass SJ, Omenn GS, CotRoO-BTfPPOiC, Services BoHC, Policy BoHS Evolution of Translational Omics: Lessons Learned and the Path Forward. National Academy of Sciences 2012
-
(2012)
National Academy of Sciences
-
-
Micheel, C.M.1
Nass, S.J.2
Omenn, G.S.3
-
21
-
-
84886447263
-
A blood-based proteomic classifier for the molecular characterization of pulmonary nodules
-
Li XJ, Hayward C, Fong PY, A blood-based proteomic classifier for the molecular characterization of pulmonary nodules. Sci Transl Med 2013 5 207ra142
-
(2013)
Sci Transl Med
, vol.5
, pp. 207ra142
-
-
Li, X.J.1
Hayward, C.2
Fong, P.Y.3
-
22
-
-
64549125924
-
Multiple reaction monitoring for quantitative biomarker analysis in proteomics and metabolomics
-
Kitteringham NR, Jenkins RE, Lane CS, Elliott VL, Park BK, Multiple reaction monitoring for quantitative biomarker analysis in proteomics and metabolomics. J Chromatogr B Analyt Technol Biomed Life Sci 2009 877 1229 1239
-
(2009)
J Chromatogr B Analyt Technol Biomed Life Sci
, vol.877
, pp. 1229-1239
-
-
Kitteringham, N.R.1
Jenkins, R.E.2
Lane, C.S.3
Elliott, V.L.4
Park, B.K.5
-
23
-
-
54049090766
-
Selected reaction monitoring for quantitative proteomics: A tutorial
-
Lange V, Picotti P, Domon B, Aebersold R, Selected reaction monitoring for quantitative proteomics: a tutorial. Mol Syst Biol 2008 4 222
-
(2008)
Mol Syst Biol
, vol.4
, pp. 222
-
-
Lange, V.1
Picotti, P.2
Domon, B.3
Aebersold, R.4
-
24
-
-
0037422847
-
Towards complete and accurate reporting of studies of diagnostic accuracy: The stard initiative
-
Bossuyt PM, Reitsma JB, Bruns DE, Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative. Ann Intern Med 2003 138 40 44
-
(2003)
Ann Intern Med
, vol.138
, pp. 40-44
-
-
Bossuyt, P.M.1
Reitsma, J.B.2
Bruns, D.E.3
-
26
-
-
84935922097
-
An integrated quantification method to increase the precision, robustness, and resolution of protein measurement in human plasma samples
-
Li X, Lee LW, Hayward C, An integrated quantification method to increase the precision, robustness, and resolution of protein measurement in human plasma samples. Kearney Clinical Proteomics 2015 12 3
-
(2015)
Kearney Clinical Proteomics
, vol.12
, pp. 3
-
-
Li, X.1
Lee, L.W.2
Hayward, C.3
-
27
-
-
0041833610
-
Partial auc estimation and regression
-
Dodd LE, Pepe MS, Partial AUC estimation and regression. Biometrics 2003 59 614 623
-
(2003)
Biometrics
, vol.59
, pp. 614-623
-
-
Dodd, L.E.1
Pepe, M.S.2
-
28
-
-
84874971341
-
Key multiplicity issues in clinical drug development
-
Dmitrienko A, D'Agostino RB Sr, Huque MF., Key multiplicity issues in clinical drug development. Stat Med 2013 32 1079 1111
-
(2013)
Stat Med
, vol.32
, pp. 1079-1111
-
-
Dmitrienko, A.1
D'Agostino, R.B.S.R.2
Huque, M.F.3
-
30
-
-
84880334927
-
Bridging the clinical gaps: Genetic, epigenetic and transcriptomic biomarkers for the early detection of lung cancer in the post-national lung screening trial era
-
Brothers JF, Hijazi K, Mascaux C, El-Zein RA, Spitz MR, Spira A, Bridging the clinical gaps: genetic, epigenetic and transcriptomic biomarkers for the early detection of lung cancer in the post-National Lung Screening Trial era. BMC Med 2013 11 168
-
(2013)
BMC Med
, vol.11
, pp. 168
-
-
Brothers, J.F.1
Hijazi, K.2
Mascaux, C.3
El-Zein, R.A.4
Spitz, M.R.5
Spira, A.6
-
31
-
-
84874385423
-
Definition of a positive test result in computed tomography screening for lung cancer: A cohort study
-
International Early Lung Cancer Action Program Investigators
-
Henschke CI, Yip R, Yankelevitz DF, Smith JP, International Early Lung Cancer Action Program Investigators Definition of a positive test result in computed tomography screening for lung cancer: a cohort study. Ann Intern Med 2013 158 246 252
-
(2013)
Ann Intern Med
, vol.158
, pp. 246-252
-
-
Henschke, C.I.1
Yip, R.2
Yankelevitz, D.F.3
Smith, J.P.4
-
32
-
-
20144389751
-
Ct screening for lung cancer: Five-year prospective experience
-
Swensen SJ, Jett JR, Hartman TE, CT screening for lung cancer: five-year prospective experience. Radiology 2005 235 259 265
-
(2005)
Radiology
, vol.235
, pp. 259-265
-
-
Swensen, S.J.1
Jett, J.R.2
Hartman, T.E.3
-
33
-
-
80355129626
-
Screening by chest radiograph and lung cancer mortality: The prostate, lung, colorectal, and ovarian (plco) randomized trial
-
PLCO Project Team
-
Oken MM, Hocking WG, Kvale PA, PLCO Project Team Screening by chest radiograph and lung cancer mortality: the prostate, lung, colorectal, and ovarian (PLCO) randomized trial. JAMA 2011 306 1865 1873
-
(2011)
JAMA
, vol.306
, pp. 1865-1873
-
-
Oken, M.M.1
Hocking, W.G.2
Kvale, P.A.3
-
34
-
-
84863617592
-
Ct scan screening for lung cancer: Risk factors for nodules and malignancy in a high-risk urban cohort
-
Greenberg AK, Lu F, Goldberg JD, CT scan screening for lung cancer: risk factors for nodules and malignancy in a high-risk urban cohort. PLoS One 2012 7 e39403
-
(2012)
PLoS One
, vol.7
, pp. e39403
-
-
Greenberg, A.K.1
Lu, F.2
Goldberg, J.D.3
-
35
-
-
84877961632
-
Results of initial low-dose computed tomographic screening for lung cancer
-
Church TR, Black WC, Aberle DR, Results of initial low-dose computed tomographic screening for lung cancer. N Engl J Med 2013 368 1980 1991
-
(2013)
N Engl J Med
, vol.368
, pp. 1980-1991
-
-
Church, T.R.1
Black, W.C.2
Aberle, D.R.3
-
36
-
-
0026375218
-
Prospective study of pulmonary function and lung cancer
-
Nomura A, Stemmermann GN, Chyou PH, Marcus EB, Buist AS, Prospective study of pulmonary function and lung cancer. Am Rev Respir Dis 1991 144 307 311
-
(1991)
Am Rev Respir Dis
, vol.144
, pp. 307-311
-
-
Nomura, A.1
Stemmermann, G.N.2
Chyou, P.H.3
Marcus, E.B.4
Buist, A.S.5
-
37
-
-
38849091997
-
Evaluating the added predictive ability of a new marker: From area under the roc curve to reclassification and beyond
-
discussion 207
-
Pencina MJ, D'Agostino RB Sr, D'Agostino RB Jr, Vasan RS, Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med 2008 27 157 72; discussion 207
-
(2008)
Stat Med
, vol.27
, pp. 157-172
-
-
Pencina, M.J.1
D'Agostino, R.B.S.R.2
D'Agostino, R.B.3
Vasan, R.S.4
-
38
-
-
68949207895
-
Glycoproteomic analysis of human lung adenocarcinomas using glycoarrays and tandem mass spectrometry: Differential expression and glycosylation patterns of vimentin and fetuin a isoforms
-
Rho JH, Roehrl MH, Wang JY, Glycoproteomic analysis of human lung adenocarcinomas using glycoarrays and tandem mass spectrometry: differential expression and glycosylation patterns of vimentin and fetuin A isoforms. Protein J 2009 28 148 160
-
(2009)
Protein J
, vol.28
, pp. 148-160
-
-
Rho, J.H.1
Roehrl, M.H.2
Wang, J.Y.3
-
39
-
-
84899823027
-
Fructose-bisphosphate aldolase a is a potential metastasis-Associated marker of lung squamous cell carcinoma and promotes lung cell tumorigenesis and migration
-
Du S, Guan Z, Hao L, Fructose-bisphosphate aldolase A is a potential metastasis-Associated marker of lung squamous cell carcinoma and promotes lung cell tumorigenesis and migration. PLoS One 2014 9 e85804
-
(2014)
PLoS One
, vol.9
, pp. e85804
-
-
Du, S.1
Guan, Z.2
Hao, L.3
-
40
-
-
4143055900
-
Overexpression of collagen xviii is associated with poor outcome and elevated levels of circulating serum endostatin in non-small cell lung cancer
-
Iizasa T, Chang H, Suzuki M, Overexpression of collagen XVIII is associated with poor outcome and elevated levels of circulating serum endostatin in non-small cell lung cancer. Clin Cancer Res 2004 10 5361 5366
-
(2004)
Clin Cancer Res
, vol.10
, pp. 5361-5366
-
-
Iizasa, T.1
Chang, H.2
Suzuki, M.3
-
41
-
-
77449144795
-
Expression of ftl and fth genes encoding ferretin subunits in lung and renal carcinomas
-
Kudriavtseva AV, Anedchenko EA, Oparina NIu, [Expression of FTL and FTH genes encoding ferretin subunits in lung and renal carcinomas]. Mol Biol (Mosk) 2009 43 1044 1054
-
(2009)
Mol Biol (Mosk
, vol.43
, pp. 1044-1054
-
-
Kudriavtseva, A.V.1
Anedchenko, E.A.2
Oparina, N.3
-
42
-
-
84904597462
-
Extracellular galectin-3 in tumor progression and metastasis
-
Fortuna-Costa A, Gomes AM, Kozlowski EO, Stelling MP, Pavão MS, Extracellular galectin-3 in tumor progression and metastasis. Front Oncol 2014 4 138
-
(2014)
Front Oncol
, vol.4
, pp. 138
-
-
Fortuna-Costa, A.1
Gomes, A.M.2
Kozlowski, E.O.3
Stelling, M.P.4
Pavão, M.S.5
-
43
-
-
25444520281
-
Prognostic significance of endogenous adhesion/growth-regulatory lectins in lung cancer
-
Szoke T, Kayser K, Baumhakel JD, Prognostic significance of endogenous adhesion/growth-regulatory lectins in lung cancer. Oncology 2005 69 167 174
-
(2005)
Oncology
, vol.69
, pp. 167-174
-
-
Szoke, T.1
Kayser, K.2
Baumhakel, J.D.3
-
44
-
-
84885081970
-
Thrombospondin-1 mediates oncogenic ras-induced senescence in premalignant lung tumors
-
Baek KH, Bhang D, Zaslavsky A, Thrombospondin-1 mediates oncogenic Ras-induced senescence in premalignant lung tumors. J Clin Invest 2013 123 4375 4389
-
(2013)
J Clin Invest
, vol.123
, pp. 4375-4389
-
-
Baek, K.H.1
Bhang, D.2
Zaslavsky, A.3
-
45
-
-
84858766991
-
A multiplexed serum biomarker immunoassay panel discriminates clinical lung cancer patients from high-risk individuals found to be cancer-free by ct screening
-
Bigbee WL, Gopalakrishnan V, Weissfeld JL, A multiplexed serum biomarker immunoassay panel discriminates clinical lung cancer patients from high-risk individuals found to be cancer-free by CT screening. J Thorac Oncol 2012 7 698 708
-
(2012)
J Thorac Oncol
, vol.7
, pp. 698-708
-
-
Bigbee, W.L.1
Gopalakrishnan, V.2
Weissfeld, J.L.3
-
46
-
-
84893852473
-
Large-scale, ion-current-based proteomics investigation of bronchoalveolar lavage fluid in chronic obstructive pulmonary disease patients
-
Tu C, Mammen MJ, Li J, Large-scale, ion-current-based proteomics investigation of bronchoalveolar lavage fluid in chronic obstructive pulmonary disease patients. J Proteome Res 2014 13 627 639
-
(2014)
J Proteome Res
, vol.13
, pp. 627-639
-
-
Tu, C.1
Mammen, M.J.2
Li, J.3
-
47
-
-
84867116844
-
Repeatability of and relationship between potential COPD biomarkers in bronchoalveolar lavage, bronchial biopsies, serum, and induced sputum
-
Röpcke S, Holz O, Lauer G, Repeatability of and relationship between potential COPD biomarkers in bronchoalveolar lavage, bronchial biopsies, serum, and induced sputum. PLoS One 2012 7 e46207
-
(2012)
PLoS One
, vol.7
, pp. e46207
-
-
Röpcke, S.1
Holz, O.2
Lauer, G.3
-
48
-
-
84880448658
-
Identification of proteomic signatures associated with lung cancer and COPD
-
Pastor MD, Nogal A, Molina-Pinelo S, Identification of proteomic signatures associated with lung cancer and COPD. J Proteomics 2013 89 227 237
-
(2013)
J Proteomics
, vol.89
, pp. 227-237
-
-
Pastor, M.D.1
Nogal, A.2
Molina-Pinelo, S.3
-
49
-
-
33847167612
-
A clinical model to estimate the pretest probability of lung cancer in patients with solitary pulmonary nodules
-
Veterans Affairs SNAP Cooperative Study Group
-
Gould MK, Ananth L, Barnett PG, Veterans Affairs SNAP Cooperative Study Group A clinical model to estimate the pretest probability of lung cancer in patients with solitary pulmonary nodules. Chest 2007 131 383 388
-
(2007)
Chest
, vol.131
, pp. 383-388
-
-
Gould, M.K.1
Ananth, L.2
Barnett, P.G.3
|